title: Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: study using Carnoy's fixation and immunohistochemistry for detection of bacteria.
abstract: BACKGROUND
  There is controversy about the effect of acid-suppressive therapy on Helicobacter pylori density and the severity of histological gastritis in the corpus.
  
  
  OBJECTIVE
  To evaluate the precise distribution of H. pylori, both on the surface mucus cells and in the surface mucus gel layer, by using Carnoy's fixation and immunostaining for the detection of bacteria.
  
  
  METHODS
  A total of 19 peptic ulcer patients with H. pylori infection were studied. All patients received a 6-week course of treatment with omeprazole (20 mg/day). Before and after the therapy, H. pylori density in Carnoy-fixed tissue sections was examined immunohistochemically. The effect of omeprazole therapy on the severity of gastritis was also evaluated.
  
  
  RESULTS
  H. pylori density and the grade of gastritis significantly decreased in the antrum after omeprazole therapy. In the corpus, however, there were no significant changes in H. pylori density or the severity of gastritis after omeprazole therapy.
  
  
  CONCLUSIONS
  Carnoy's fixation and immunostaining was found to be useful for the detection of H. pylori in the surface mucus gel layer as well as on the surface mucus cells in biopsy tissue sections. By using this method, H. pylori density decreased in the antrum, but remained unchanged in the corpus after a 6-week course of omeprazole therapy.
authors.affiliation: Department of Internal Medicine II, Shimane Medical University, Izumo, Shimane, Japan. si360405@shimane-med.ac.jp
authors.forename: S
authors.initials: S
authors.lastname: Ishihara
authors.forename: T
authors.initials: T
authors.lastname: Okuyama
authors.forename: N
authors.initials: N
authors.lastname: Ishimura
authors.forename: M
authors.initials: M
authors.lastname: Ono
authors.forename: T
authors.initials: T
authors.lastname: Hashimoto
authors.forename: H
authors.initials: H
authors.lastname: Kazumori
authors.forename: T
authors.initials: T
authors.lastname: Kaji
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: H
authors.initials: H
authors.lastname: Fujishiro
authors.forename: K
authors.initials: K
authors.lastname: Adachi
authors.forename: R
authors.initials: R
authors.lastname: Fukuda
authors.forename: Y
authors.initials: Y
authors.lastname: Kinoshita
mesh_terms: D019342:Acetic Acid; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002725:Chloroform; D000431:Ethanol; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D000897:Anti-Ulcer Agents; C033474:Carnoy's solution; D000431:Ethanol; D002725:Chloroform; D009853:Omeprazole; D019342:Acetic Acid